|
|
Nussdorfer Lande 11 Vienna, A-1190 Austria phone:(43) 1360 066 203 fax:(43) 1369 7615
|
|
| Symbol |
Private |
| Founded |
0 |
| Employees |
|
|
|
| www.polymun.com
|
|
| Research Sector |
Biotech Specialty Pharma |
|
 |
| Summary Description |
| Development of bio-processes, vaccines and biopharmaceuticals for human application. |
 |
| Management |
| Hermann Katinger, Founder and Chief Executive Officer |
| |
|
|
| |
|
| Keywords |
| bio-process, vaccine, biopharmaceutical, monoclonal, antibody, hiv, liposomes, influenze, HIVAIDS |
|
|
|
| Description |
|
POLYMUN Scientific develops industrial bio-processes, vaccines and biopharmaceuticals for human application - for contract partners and for POLYMUN's own proprietary R&D-pipeline. |
 |
| Technology / Differentiation |
| POLYMUN has generated fully human monoclonal antibodies against unique HIV-antigens which are now much used reference antibodies in the world wide HIV-1 research (2F5, 2G12 and 4E10). POLYMUN's proprietary R&D pipeline includes a Anti-HIV vaccine and a live-Influenza vaccine. POLYMUN has established a highly reproducible technology for the incorporation of drugs into liposomes. |
 |
 |
|
|
|
|
|
|